Washington Gov. Jay Inslee and Boeing hailed Friday's vote, which proponents said solidifies the aerospace giant's presence in the Seattle area.
"Tonight, Washington state secured its future as the aerospace capital of the world," Inslee declared.
Under the terms of the eight-year contract extension, Boeing said the 777X and its composite wing will be built in the Puget Sound area by Boeing employees represented by the Machinists union.
"Thanks to this vote by our employees, the future of Boeing in the Puget Sound region has never looked brighter," Boeing Commercial Airplanes President and CEO Ray Conner said. "We're proud to say that together, we'll build the world's next great airplane ��the 777X and its new wing ��right here. This will put our workforce on the cutting edge of composite technology, while sustaining thousands of local jobs for years to come."
Top Electric Utility Companies To Buy For 2015: United Therapeutics Corporation(UTHR)
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases in the United States and internationally. It offers Remodulin, Tyvaso, and Adcirca for the treatment of pulmonary arterial hypertension (PAH). The company also develops Oral Treprostinil (UT-15C), a new drug application filed with the United States Food and Drug Administration for the treatment of PAH. Its development products under Phase III clinical trials include Oral Treprostinil (UT-15C) Combination Therapy for PAH; Ch14.18 monoclonal antibody (MAb) targeting Neuroblastoma; and Remodulin for the treatment of PAH in the United States, the United Kingdom, France, Germany, Italy, and Japan. The company?s development products under Phase I clinical trials comprise Beraprost-MR for PAH in North America, Europe, Mexico, South America, Egypt, India, South Africa, and Australia; 8H9 MAb targ eting Metastatic brain cancer; and IW001 for the treatment of Idiopathic pulmonary fibrosis and primary graft dysfunction. Its pre-clinical stage products consist of Glycobiology Antiviral Agents for viral infectious diseases; PLacental eXpanded cells targeting PAH; and pulmonary tissue replacement and remodeling products for the treatment of end-stage lung disease. The company serves pharmaceutical wholesalers through specialty pharmaceutical distributors and other distributors. United Therapeutics Corporation was founded in 1996 and is headquartered in Silver Spring, Maryland.
Advisors' Opinion:- [By Monica Gerson]
United Therapeutics (NASDAQ: UTHR) shares reached a new 52-week high of $91.13. United Therapeutics' PEG ratio is 1.64.
DENTSPLY International (NASDAQ: XRAY) shares touched a new 52-week high of $47.65. DENTSPLY's trailing-twelve-month ROE is 15.95%.
- [By Ben Levisohn]
Look up in the sky! It’s a bird! It’s a plane! It’s Santa Claus! No. It’s United Therapeutics (UTHR).
ReutersShares of the United Therapeutics have surged 23% to $107.65, on what’s looking to be a pretty decent day for biotech stocks. The iShares Nasdaq Biotechnology Index ETF (IBB) has gained 0.9% to $225.75, as Gilead Sciences (GILD) has risen 0.7% to $75.16 and Celgene (CELG) has ticked up 0.4% to $168.09.
- [By George Budwell]
United Therapeutics (NASDAQ: UTHR ) soared over 30% last week after receiving approval from the Food and Drug Administration for its extended-release oral tablets for pulmonary arterial hypertension, or PAH, known as Orenitram. This approval marks the company's fifth with the FDA for PAH, which is currently the company's primary revenue generator. Looking ahead, this approval should help to grow United Therapeutics revenue by 5% to 10% next year.
- [By John Udovich]
Yesterday, mid cap biotech stock�United Therapeutics Corporation (NASDAQ: UTHR) soared�30.36% after announced FDA approval of Orenitram as�an oral treatment for pulmonary arterial hypertension (PAH), meaning investors should take a closer look at the stock along with the performance of peers like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and the�SPDR S&P Biotech ETF (NYSEARCA: XBI).
Top 10 Gas Utility Stocks To Buy Right Now: RadNet Inc.(RDNT)
RadNet, Inc. provides outpatient diagnostic imaging services in the United States. The company offers various imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and other related procedures. It also provides teleradiology services to radiology groups, hospitals, and imaging centers. In addition, the company offers picture archiving and communications systems and related workflow solutions for hospitals, teleradiology businesses, imaging centers, and specialty physician groups to distribute, visualize, store, and retrieve digital images taken from various diagnostic imaging modalities. As of December 31, 2011, it operated 233 diagnostic imaging facilities in California, Delaware, Maryland, New Jersey, Rhode Island, Florida, and New York. RadNet, Inc. was founded in 1985 and is headquartered in Los Angeles, California.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
Alamy There are plenty of stocks going up -- and down -- in any given week. The gainers inspire us to keep investing. The decliners keep greed in check while reminding us about the risks of the equity markets. Let's go over some of last week's best and worst performers. Pike (PIKE) -- Up 49 percent last week The market's biggest winner of last week was Pike, a specialty construction and engineering firm that received a bid to be taken private. J. Eric Pike -- the firm's chairman and CEO -- is teaming up with private equity firm Court Square Capital Partners to buy out shareholders at $12 a share. It's a fair premium, pricing the buyout at a better than 50 percent premium to where the stock was trading when it was announced. A few attorneys are trying to smoke out investors who feel that the CEO-led privatization push isn't fair, but it's likely to stick at that kind of healthy markup. Pike shares may have traded in the low teens last summer, but that was before revenue and earnings began heading the wrong way. Most shareholders should be more than happy to take the money and run. RadNet (RDNT) -- Up 34 percent last week Operating a network of 251 facilities that perform outpatient diagnostic imaging services is looking good for RadNet. The stock moved sharply higher after a strong quarterly report. Revenue inched slighting higher as MRI and CT scan volume increased modestly during the period. However, the real star in the report was RadNet's bottom line. Its cost-cutting and debt-slashing efforts paid off with net income soaring to $0.12 a share after clocking in at a $0.07 a share a year earlier. Analysts were only holding out for $0.05 a share. RadNet also helped improve its standing by boosting its guidance for all of 2014. You don't need any of RadNet's fancy imaging equipment to see that that's a healthy sign. Trex (TREX) -- Up 25 percent last week It was a good week for a pair of home improvement specialists. Shares of CaesarStone (CSTE) moved 20
Top 10 Gas Utility Stocks To Buy Right Now: Toshiba Corp (TOSBF)
TOSHIBA CORPORATION is a Japan-based manufacturer that operates in five business segments. The Digital Product segment manufactures and sells cellular phones, hard disc devices, optical disc devices, televisions among others. The Electronic Device segment provides general logic integrated circuits (ICs), optical semiconductors, power devices, large-scale integrated (LSI) circuits, among others. The Social Infrastructure segment manufactures and sells various generators, power distribution systems, water and sewer systems, transportation systems and station automation systems, among others. The Home Appliance segment provides refrigerators, drying machines, washing machines, cooking utensils, cleaners and lighting equipment, among others. The Others segment is involved in the provision of logistics services. In January 2014, Toshiba Corp purchased substantially all assets of OCZ Technology Group, and launched new subsidiary, OCZ Storage Solutions. Advisors' Opinion:- [By Dan Carroll and Max Macaluso, Ph.D.]
Panasonic's (NASDAQOTH: PCRFY ) not the first company you may think of in the health-care field, but this Japanese electronics maker's a player in blood glucose monitors and other fields. With Panasonic's sales under fire across the board, however, this company's looking to sell off its health-care business to refocus on its core segments. Toshiba (NASDAQOTH: TOSBF ) reportedly has expressed interest in a buy, and private equity-firms are also in the hunt to get on board with Asia's health-care rise.
- [By Bruce Kennedy]
On Monday, U.S. Attorney General Eric Holder announced indictments against five officers in China's People's Liberation Army (PLA) for ��erious cybersecurity breaches��against six American firms: Westinghouse Electric, a division of Toshiba (OTC: TOSBF) , Alcoa (NYSE: AA),�Allegheny Technologies (NYSE: ATI), U.S. Steel (NYSE: X), the United Steelworkers Union and SolarWorld (OTC: SRWRY).
Top 10 Gas Utility Stocks To Buy Right Now: AbbVie Inc (ABBV)
AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based pharmaceuticals company. The Company discovers, develops, and commercializes advanced therapies. AbbVie's portfolio of products include a line of adult and pediatric pharmaceuticals, which includes HUMIRA, metabolics/hormones products, virology products, endocrinology products, dyslipidemia products and other products.
AbbVie products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, human immunodeficiency virus (HIV), cystic fibrosis complications, low testosterone, thyroid disease, Parkinson's disease and complications associated with chronic kidney disease, among other indications. In October 2012, AbbVie initiated a comprehensive Phase III program for hepatitis C virus (HCV) genotype one.
Advisors' Opinion:- [By Johanna Bennett]
British drug maker Shire (SHPG) turned up its nose at the $46.5 billion offer by U.S. rival AbbVie (ABBV), in the latest move by a U.S. company to pursue a deal for a company with a lower tax rate. Simply put, Shire says the bid is to low and released ambitious new targets to more than double its annual sales to $10 billion by 2020.
- [By Ben Levisohn]
Abbvie (ABBV)
Ameren Corp. (AEE)
Arthur J. Gallagher (AJG)
E.I. DuPont de Nemours & Co. (DD)
ENSCO (ESV)
Enterprise Products Partners LP (EPD)
General Mills (GIS)
H&R Block (HRB)
Hancock Holding (HBHC)
Kraft Foods Group (KRFT)
Lorillard (LO)
Magellan Midstream Partners LP (MMP)
MarkWest Energy Partners L P (MWE)
McDonald’s (MCD)
Microchip Technology (MCHP)
NextEra Energy (NEE)
Regency Centers (REG)
TELUS Corp. (TU)
West Corp. (WSTC)
Williams Companies (WMB) - [By Sean Williams]
The next big thing in treating hepatitis-C
The other currently experimental therapy very likely to make it onto the FDA's desk before the midpoint of 2014 is AbbVie's (NYSE: ABBV ) direct-acting antiviral combo drug. In similar fashion to Sovaldi, this DAA-combo therapy, which includes ABT-450 from Enanta Pharmaceuticals (NASDAQ: ENTA ) , is running six confirmatory late-stage trials on various genotypes. There are, however, two primary differences between AbbVie's DAA-combo therapy and Sovaldi. - [By Wallace Witkowski]
Heavyweights in the S&P 500 such as Apple Inc. (AAPL) , Microsoft Corp. (MSFT) �, Comcast Corp. (CMCSA) , Cisco Systems Inc. (CSCO) , AbbVie Inc. (ABBV) , Honeywell Corp. (HON) , Priceline.com Inc. (PCLN) , DuPont (DD) , Dow Chemical Co. (DOW) , Monsanto Co. (MON) , and Starbucks Corp. (SBUX) �all saw a 20% or more jump in the number of short-interest positions in the past two weeks alone, according to FactSet data.
Top 10 Gas Utility Stocks To Buy Right Now: Ibio Inc (IBIO)
iBio, Inc. (iBio), incorporated on April 17, 2008, is a biotechnology company focused on commercializing its technologies, the iBioLaunch platform for vaccines and therapeutic proteins, as well as the iBioModulator platform for vaccine enhancement. Vaccine candidates on its platform are applicable to newly emerging strains of hemagglutinin type 1 and neuraminidase type 1 (H1N1), swine-like influenza, hemagglutinin type 5 and neuraminidase type 1 (H5N1) avian influenza, yellow fever, and anthrax. The Company licenses or otherwise grants use rights to government and non-governmental organization (NGO) entities for not-for-profit applications of the intellectual property for the development or application for which they granted or were granted funding, and to Fraunhofer USA, Inc. (FhCMB) for research purposes and applications in other fields.
The Company�� platform technology is referred to as iBioLaunch technology or the iBioLaunch platform, and the category of this technology is referred to as plant-based technology or as a plant-based platform. The Company has exclusive control over, and the rights to ownership of, the intellectual property related to all human health and veterinary influenza applications of the plant-based technology developed by FhCMB. Its property consists of the technology platform pursuant, to which hydroponically grown green plants can be used for the accelerated development and manufacture of high-value proteins of interest as candidate therapeutic products and vaccines applicable to a range of disease agents, such as influenza, sleeping sickness, anthrax, plague, human papillomavirus (HPV), and veterinary influenza applications.
Through FhCMB and their funding from the Bill & Melinda Gates Foundation, it is developing vaccine candidates targeting pathogenic avian influenza (H5N1) viruses based upon the iBioLaunch platform. These candidates have demonstrated immunogenicity and have been successfully tested in mice and ferrets for protective efficacy.! Like its candidate vaccines for seasonal influenza, its candidate vaccines for avian influenza are subunit vaccines. iBio has commercial rights to vaccine candidates developed pursuant to its business structure based on fusing a protein component of HPV called the E7 antigen, to the LicKM protein of the bacterium Clostridium thermocellum. It has commercial rights to an oral anthrax booster vaccine candidate developed by FhCMB in collaboration with the Naval Medical Research Center (NMRC).
Advisors' Opinion:- [By James E. Brumley]
With just a quick glance, Ibio Inc. (NYSEMKT:IBIO) doesn't look like anything particularly special. The stock's just bouncing around, and we've not heard any particularly meaningful news from IBIO in a few weeks.
- [By Bryan Murphy]
If the name Ibio Inc. (NYSEMKT:IBIO) rings a bell, it may be because I put some bullish thoughts into print regarding the stock back on June 21st. I reiterated my optimism on July 12th. What can I say? It's fun to be right. IBIO shares have advanced 17% since my first look in late June. Then again, most of that big jump has unfurled in the last couple of days, meaning Ibio Inc. is overbought. Do we trust the breakout move, or do we fear a pullback? Answer: That depends.
Top 10 Gas Utility Stocks To Buy Right Now: Meru Networks Inc.(MERU)
Meru Networks, Inc., together with its subsidiaries, provides wireless local area network (LAN) solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers a virtualized wireless LAN solution based on its System Director Operating System, which runs on its controllers and access points to enable enterprises to deliver business-critical applications over wireless networks. The company?s System Director Operating System provides centralized coordination and control of various access points on the network; controllers synchronize access points to optimize the user experience and manage traffic on the network; and Wi-Fi certified access points to provide network connectivity for wireless devices. It also offers Meru Networks E(z)RF application suite comprising E(z)RF Network Manager, E(z)RF Service Assurance Manager, E(z)RF Location Manager, E(z)RF OnTheGo, Spectrum Manager, and wired and wireless management solutions, which enable enterprises to configure, monitor, troubleshoot, secure, and operate virtualized wireless LAN solution. In addition, the company provides Identity Manager that simplifies enterprise network access and identity management; Wireless Intrusion Prevention System to recognize and mitigate threats; Compliance Manager to reduce the risk of security breach by protecting customer and employee personal information by extending security to the wireless network; AirFirewall to intercept and block unwanted communications as they transmit over the air, stopping them before they reach the network; and Security Gateway SG1000 to meet the demands of the Federal Information Processing Standard, 140-2 Level 3 security required by federal government agencies and other security-conscious organizations. It serves the education, healthcare, hospitality, manufacturing, retail, technology, finance, government, telecom, transportation, and utility markets. The company was founded in 2002 and is headquartered in Sunnyvale, California.
Advisors' Opinion:- [By Eric Volkman]
Meru Networks (NASDAQ: MERU ) isn't wasting any time in finding a successor to one of its top executives. The company announced Monday it had appointed Brian McDonald to be its new CFO to replace the resigning Brett White. McDonald took up his position today, although White will remain at the firm through July 1 in order "to effect a smooth transition."
Top 10 Gas Utility Stocks To Buy Right Now: athenahealth Inc.(ATHN)
athenahealth, Inc., a business services company, provides ongoing billing, clinical-related, and other related services to medical group practices primarily in the United States. It provides services through the athenaNet, a proprietary Internet-based practice management application. The company primarily offers athenaCollector, a revenue cycle management service that automates and manages billing-related functions for physician practices, and includes a practice management platform. The athenaCollector assists its physician clients with the handling of claims and billing processes to help manage reimbursement. The company also provides Anodyne Analytics, a business intelligence application, which provides physicians and practice managers with insight into practice performance. In addition, it offers athenaClinicals, an electronic health record service that automates and manages medical-record-management-related functions for physician practices, as well as assists medical groups with the handling of physician documentation, orders, and related inbound and outbound communications. Further, the company provides athenaCommunicator that allows practices to manage patient communication tasks electronically, including the use of automated reminder calls; the creation of a self-service patient portal for registration, appointment requests, bill payments, and general communication; automatic generation of emails to patients; and patient education tools. It sells its products through a direct sales force, as well as through channel partners. The company was formerly known as athenahealth.com, Inc. and changed its name to athenahealth, Inc. in November 2000. athenahealth, Inc. was incorporated in 1997 and is headquartered in Watertown, Massachusetts.
Advisors' Opinion:- [By Jon C. Ogg]
Athenahealth Inc. (NASDAQ: ATHN) was downgraded to Market Perform from Outperform at Leerink Swann.
BlackBerry Ltd. (NASDAQ: BBRY) was raised to Hold from Sell at Canaccord Genuity, but only now that a first buyout offer has put in a likely floor.
- [By Keith Speights]
Miss and score?
Athenahealth� (NASDAQ: ATHN ) missed analysts' expectations for earnings. Did the stock fall as a result? Nope. Instead, shares flew 20% higher for the week. What's going on?
No comments:
Post a Comment